None listed
Conditions
Interventions
None listed
Sponsors
Ajou University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult over 19 years old 2) Patients treated with D+storm sirolimus elutating coronary stent 3) Patients who agree to a Protocol and a clinical follow-up survey plan and who have agreed in writing to a patient consent form approved by the clinical Institutional Review Board of each research institute.
Exclusion criteria
Exclusion criteria: 1) Patients treated with drug elution stents other than D+ storm 2) Patients with a life expectancy of less than a year 3) A psychogenic shock patient 4) Patients with a left ventricular ejection fraction of less than 30% 5) A woman of a possible pregnancy age who plans to conceive during this study. 6) Patients who are judged to be inappropriate to participate in the study by other investigator 7) Subjects who are scheduled to undergo surgery that requires the discontinuation of antiplatelet drugs within 12 months of registration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coronary artery intervention procedure death at the point of 12 months' time, myocardial infarction or Compound clinical events in the occurrence of Target Lesion Revaccination (TLR) | — |
Secondary
| Measure | Time frame |
|---|---|
| All deaths.;Cardiac death.;Myocardial infarction (MI);Target vessel revascularization (TVR);Target Lesion revascularization (TLR);Stent thrombosis (ARC standard);Successfully procedure | — |
Countries
Korea, Republic of
Contacts
Public ContactHyoung-Mo Yang
Ajou University Hospital
Outcome results
None listed